Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients

BackgroundLymphocytes are crucial in the pathogenesis of inflammatory bowel disease (IBD) and are an important target for drug development. Our aim was to verify whether 2 vitamin D derivatives, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and EB 1089, could induce cell apoptosis and affect cell–cell inte...

Full description

Saved in:
Bibliographic Details
Published inInflammatory bowel diseases Vol. 14; no. 5; pp. 597 - 604
Main Authors Martinesi, Maria, Treves, Cristina, d'Albasio, Giuseppe, Bagnoli, Siro, Bonanomi, Andrea G., Stio, Maria
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford University Press 01.05.2008
Wiley Subscription Services, Inc., A Wiley Company
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundLymphocytes are crucial in the pathogenesis of inflammatory bowel disease (IBD) and are an important target for drug development. Our aim was to verify whether 2 vitamin D derivatives, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and EB 1089, could induce cell apoptosis and affect cell–cell interaction by regulating adhesion molecule levels.MethodsPeripheral blood mononuclear cell (PBMC) proliferation was studied by [3H]thymidine incorporation and apoptosis was determined using an enzyme-linked immunosorbent assay (ELISA) kit. (Poly(ADP-ribose)polymerase (PARP) cleavage, caspase-3, and ICAM-1 protein levels were determined by Western blot analysis.ResultsOur results indicate that 1,25(OH)2D3 or EB 1089 or anti-TNF-α (infliximab) induce apoptosis in PBMC obtained from healthy subjects. In IBD patients apoptosis is induced by vitamin D derivatives and by anti-TNF-α only in CD patients. Caspase-3 activation and PARP cleavage are registered when PBMC were treated with vitamin D derivatives. ICAM-1 levels remarkably increase when PBMC was incubated with lipopolysaccharide (LPS) or TNF-α. The treatment with the vitamin D derivatives, alone or in combination with LPS or TNF-α, significantly decreases ICAM-1 levels both in healthy subjects and IBD patients. In HUVEC cocultured with PBMC, previously incubated with LPS or TNF-α associated with 1,25(OH)2D3, ICAM-1 levels decrease both in healthy subjects and IBD patients.Conclusions1,25(OH)2D3 and EB 1089 inhibit PBMC proliferation, induce apoptosis in PBMC of healthy subjects and IBD patients, and affect ICAM-1 expression on PBMC and on HUVEC cocultured with PBMC, suggesting that the ICAM-1 downregulation could provide a new target for controlling the recruitment of leukocytes at the sites of inflammation in IBD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1078-0998
1536-4844
DOI:10.1002/ibd.20354